| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.2 | 0.002 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 2.9 | 0.003 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.003 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.39 | 0.003 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.17 | 0.004 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.2 | 0.004 |